UK Imaging Diabetes Study Seeing Diabetes Clearly
Condition(s) studied
Investigational drug(s) / intervention(s)
MRI: MRI is not part of Pathway for patient with type two diabetes.
Study summary
Prospective, observational cohort study to cross-sectionally assess the health of multiple organs, using multiparametric abdominal magnetic resonance imaging (MRI) scan, and understand if resulting MRI metrics can predict future clinical events over a period of 5 years, in adult patients with type 2 diabetes lacking history of cardiovascular disease.
Eligibility
Primary outcome measure(s)
- Baseline liver MR metrics on incidence rate of 5-point MACE (CV death, non-fatal stroke, myocardial infarction, heart failure, hospitalisation for CV causes) in people with type 2 diabetes, without history of CV. — 3 year from baseline
The impact of liver fibroinflammation (cT1 from multi-organ MRI) on cardiovascular clinical outcomes in a patient population with type 2 diabetes without history of cardiovascular disease.
Trial sites (12)
| Facility | City | Region | Status |
|---|---|---|---|
| Woodlands Medical Centre | Didcot | Oxfordshire | Recruiting |
| Eynsham Medical Centre | Eynsham | Oxfordshire | Recruiting |
| White Horse Medical Practice | Farringdon | Oxfordshire | Recruiting |
| Windrush Medical Practice | Witney | Oxfordshire | Recruiting |
| The House Partnership | Redhill | Surrey | Recruiting |
| Swansea Bay University Health Board | Baglan | Swansea | Not Yet Recruiting |
| University Hospitals of Liverpool Group | Liverpool | United Kingdom | Recruiting |
| Moorfields Eye Hospital NHS Foundation Trust | London | United Kingdom | Enrolling By Invitation |
| The Manor Group | Oxford | United Kingdom | Recruiting |
| Hedena Health | Oxford | United Kingdom | Recruiting |
| St Bartholomew and Hollow Way Medical Practice | Oxford | United Kingdom | Recruiting |
| Oxford Community Diagnostic centre | Oxford | United Kingdom | Recruiting |
More Perspectum trials in the UK
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05057403 on ClinicalTrials.gov ↗ ← All trials in the UK